Introduction: In its fiscal year 2015 final rule, the Centers for Medicare & Medicaid Services (CMS) required reporting of tobacco treatment quality measures as part of the Inpatient Psychiatric Facilities Prospective Payment System (IPF PPS). This pre-intervention, post-intervention policy analysis evaluates the impact of that policy at a large academic medical center that opted to improve performance as it implemented reporting measures. Methods: Electronic medical record data were collected retrospectively for all adult (≥18 years) inpatient psychiatric admissions from January 1, 2014 to December 31, 2015. Data from admissions were analyzed to determine changes in the provision of tobacco treatment including the proportions of patients screened for tobacco use, receiving tobacco cessation counseling, and receiving tobacco cessation medication(s) using a chi-square test. Covariate analysis of treatment differences based on psychiatric diagnosis was analyzed using Cochran-Mantel-Haenszel and Breslow-Day test. Results: Post-policy screening for admissions increased significantly (85% vs. 97%; p < .001). Referral to cessation counseling increased 18-fold (4% vs. 74%; p < .001). Receipt of Counselling (8% vs. 67%; p < .001) and referral for cessation medication (32% vs. 68%; p < .001) also increased dramatically. Though statistically non-significant, the number of tobacco users who actually received medications increased markedly between 2014 and 2015, 24% versus 35%. Gains in screening, referral, and treatment did not differ by psychiatric diagnosis. Conclusions: The Inpatient Psychiatric Facilities Quality Reporting (IPFQR) Program resulted in a 10-fold increase in the number of smokers who received inpatient tobacco treatment. Should CMS link prospective payment to performance, it could have a major impact on quality of care for tobacco dependence. Implications: This is the first study to examine the implementation and impact of new 2015 IPFQR program tobacco measures. This study may illustrate the potential effect that performance based penalties can have should facilities be required to do more than simply report on these tobacco measures. This study exemplifies the impact these new reporting measures can have when psychiatric facilities move beyond letter of the policy, to continually assess organizational performance and implement changes to improve treatment delivery.
Introduction
Patients with mental illness account for 40%-44% of the annual tobacco-consumption in the United States.
1,2 As a result, nearly half of the annual deaths attributable to smoking occur in patients with mental illness 3 and life expectancy for patients receiving public mental health treatment is 25 years below that of the general population. 4 An estimated $168 billion are spent annually in direct care for smoking-related illnesses, half of which is paid through Medicare and Medicaid, 5 which are the principle sources of health care coverage for people with severe mental illness. 6, 7 Compared to the US population as a whole, smoking prevalence among patients with mental illness has remained stagnant 8, 9 yet tobacco use remains ignored or even encouraged in mental health settings. 10 This is despite growing evidence that smoking cessation is associated with significant improvements in mental health symptoms for patients diagnosed with a psychiatric illness. 11 Furthermore, patients who receive tobacco treatment during psychiatric hospitalization have been shown to have a lower likelihood of being discharged against medical advice as well as rehospitalization when treatment is continued post discharge. 12, 13 In 1992 the Joint Commission on the Accreditation of Healthcare Organizations (JCAHO, now Joint Commission) was instrumental in implementing changes that addressed tobacco-use in healthcare facilities. However, in response to public outcry over banning smoking in psychiatric units, with advocates citing patient rights, the Joint Commission policy exempted psychiatric facilities from the indoor smoking ban. [14] [15] [16] As part of the Inpatient Psychiatric Facilities Quality Reporting (IPFQR) Program, in 2015 the Centers for Medicare & Medicaid Services (CMS) implemented new quality reporting measures targeting tobacco use screening and treatment for all inpatient psychiatric facilities receiving Medicare funds. These CMS reporting requirements, based on several new but voluntary Joint Commission measures for hospitals that were adopted in 2012, 17 represent a complete reversal of earlier policies as they are mandatory and apply specifically to inpatient psychiatric units.
Tobacco-use screening (TOB-1) assesses the number of patients screened within 3 days of admission for reported tobacco use in the last 30 days. 18 TOB-2 assesses the proportion of tobacco users who, within 3 days of admission, received or refused tobacco cessation counseling, and received or refused FDA approved cessation medications. 18 TOB-2 is, in effect, a measure of whether tobacco treatment was offered. TOB-2a measures the proportion of all identified tobacco users who actually received cessation counseling and/or medications. 18 These tobacco measures were implemented in an effort to address the health disparity that exists in the mentally ill population, and to provide consumers with the information needed to make an informed decision on where to seek care. 19 Psychiatric facilities that fail to report required measures face a 2% decrease in annual payment updates. With an estimated 1626 inpatient psychiatric facilities nationwide participating in the IPFQR program, and an estimated total of 904 056 cases reported on each year, this policy has potential to make a substantial impact on tobacco treatment among patients with mental illness. 19 At present, however, funding penalties are tied solely to whether or not a given facility "reports" these quality measures, not to how the facility "performs" on the measures.
Although not required by the rule change, the University of Kansas Hospital (KUMed) also opted to enact a number changes designed to enhance both "reporting" and "performance" on the tobacco measures. These included brief trainings on the measures with psychiatric residents at the beginning of their hospital rotation, daily monitoring of tobacco screening and treatment delivery for all new admissions and increased coordination with unit staff to ensure tobacco measures were met within the specified time period. Within the electronic medical record (EMR), a link from the nursing flow sheet was created to initiate an automatic referral to UKanQuit, KUMed's tobacco treatment service.
The purpose of this study is to examine the impact of new CMS tobacco reporting measures on the screening and provision of tobacco cessation counseling and cessation medications for inpatient psychiatric smokers. The study takes place in an academic medical center that opted to enhance performance on the measures as it created mechanisms for better reporting. Hence, this study describes the changes in documentation made in order to capture the new measures, changes in clinical practice in order to improve performance on these measures, and the resultant changes in screening and service delivery. As such, this represents an analysis of a hospital that moved beyond the letter to the spirit of the new rule. By doing so, the hospital, and this report, foreshadows the potential improvements in treatment quality that could be gained should CMS make funding updates contingent on treatment performance.
Methods

Overview
The reporting period for the new tobacco measures began on January 1, 2015. In order to evaluate its impact on hospital practices, we retrospectively abstracted electronic health record data on all admissions to KUMed's psychiatric unit the year prior to and the year immediately following policy implementation (January 1, 2014 to December 31, 2015). We cleaned the data set, imported it to SAS, and examined pre-and post-policy changes in the rates of screening, referral, and delivery of cessation counseling and cessation medications for tobacco users. We also described differences by diagnosis. This study was approved by the University of Kansas Human Subjects Committee.
Setting
KUMed is a 550-bed academic center with a 14-bed inpatient psychiatric unit. KUMed has a dedicated inpatient tobacco treatment service, UKanQuit, which provides evidence-based tobacco treatment for referred patients. UKanQuit consists of one full time equivalent (FTE) dedicated solely to providing tobacco treatment. To prevent staff burn out, this FTE is often split between 2 and 3 master's level psychologists who also staff smoking cessation clinical trials conducted by faculty at the medical school. In addition, UKanQuit includes a 0.05 FTE medical director, a 0.10 FTE clinical director, and a 0.05 FTE data manager. It was founded in 2006 when the hospital campus went smoke-free, managed by the hospital's division of Patient Care (Nursing) Services, and funded through general hospital funds. UKanQuit treatment consists of bedside smoking cessation counseling, recommendations for cessation medications both inpatient and on discharge, and referral to the state quitline for postdischarge counseling.
Participants
The study population consisted of patients admitted between January 1, 2014 and December 31, 2015 who were at least 18 years of age, and had a length of stay between 3 and 120 days.
These inclusion criteria conformed to CMS population parameters for TOB-1, TOB-2, and TOB-2a. 18 For patients with multiple admissions within a given study year, the last treatment episode was selected for inclusion in the study. Treatment episodes that spanned the two study years (began in 2013 and ended in 2014) were excluded from analysis. Study data were obtained from the hospital EMR and the UKanQuit service database and included patient demographics, inpatient medication record, inpatient tobacco treatment and smoking characteristics.
Main Outcome Measures: TOB-1, TOB-2, and TOB-2a
Concurrent with the January 1, 2015 implementation of the CMS measures, KUMed created a number of reports and new fields within the EMR to better capture tobacco use screening and referral for tobacco-related counseling and medication. These reports and fields were not, however, in place prior to the rule-in 2014. In order to avoid reporting bias, we abstracted data for TOB-1, TOB-2, and TOB-2a in exactly the same manner, from the same fields, in 2014 and 2015.
For TOB-1 (screening for tobacco use), documentation was inconsistent in 2014, prior to measure implementation. Hence, for 2014 and 2015 we counted all smokers with any evidence in the EMR of screening, tobacco use, or tobacco treatment as having been "screened." This included any documentation of tobacco use or treatment in the social history, any evidence of cessation counseling received, and any evidence of cessation medication received. Patients with missing documentation were counted as not being screened, and were also counted as nonsmokers.
Likewise, for TOB-2 (refused or received counseling/medication), documentation was inconsistent in 2014, prior to CMS measure implementation. There was, specifically, no field created until the latter part of 2014, which indicated whether a patient had been offered or refused counseling or medication. Hence, for 2014 and 2015 we defined TOB-2 as any evidence in any field of the EMR that a patient had been referred and/or received cessation counseling and/or cessation medications. Due to the inability to accurately assess whether bupropion was prescribed for cessation treatment or psychiatric treatment, bupropion was not counted as a cessation medication. Finally, we defined TOB-2a as any evidence in any field in the EMR that cessation counseling and/or that cessation medications had been received.
Psychiatric Diagnoses
We grouped cases by psychiatric diagnosis based on ICD-9 or ICD-10 classification system depending on when ICD-10 codes were implemented. These were typically the primary discharge diagnosis for each case. In the rare case in which the primary discharge diagnosis was not a psychiatric illness, we used the first secondary diagnosis listed for the patient that qualified as a psychiatric illness.
Data Analysis
Patient characteristics and primary outcome measures were summarized using descriptive and inferential statistics. Categorical variables were summarized using frequencies, and continuous variables summarized using means and standard deviations. Tests for significance included the two-sample t test for differences between means and chi-square test for differences in proportions. CochranMantel-Haenszel 20 test was used to analyze the relationship between cohort years and outcome measures after controlling for diagnoses. Breslow-Day 20 test was used to analyze odds ratio homogeneity between diagnostic groups. We used Version 9.4 of the SAS System for Windows 21 for all analyses.
Results
Study Population and Prevalence of Smoking
There were a total of 882 admissions for the two cohort years: 292 in 2014 and 338 in 2015. Across both years, 252 admissions were omitted based on exclusion criteria: Six admissions were excluded because they began December 2013 with length of stay spanning into 2014, 159 admissions had a length of stay ≤ 3 days, and 87 were duplicate admissions. At baseline, sex, race, and insurance status were the only characteristics found to be statistically different between cohort years (Table 1 ). There was a larger proportion of African Americans hospitalized in 2015, and females were more predominant in 2014. There was a higher proportion of patients with Medicare and self-pay insurance status in 2015, while private insurance status was proportionately higher in 2014. Depressive disorders and schizophrenia spectrum disorders were the predominant diagnoses in both years at 73% versus 78% in 2014 and 2015, respectively.
Tobacco Screening (TOB-1) and Identification of Tobacco Use
In 2015, there was a statistically significant increase in the proportion of patients screened for tobacco use; 328 (97%) compared to 247 (85%) in 2014, χ 2 = 30.49, df = 1, p < .001 (Table 2) . Similarly, there was an increase in the number of admissions that screened positive for tobacco use: 149 (44%) in 2015 versus 115 (39%) in 2014, however this was not statistically significant. Among tobacco users, 25 admissions in 2015 and 5 admissions in 2014 reported using smokeless tobacco products.
Notably, admissions that lacked any documentation of smoking status decreased from 45 (15%) in 2014 to 10 (3%) in 2015, χ 2 = 29.2, df = 1, p < .001 (Table 2) . However, the more complete documentation was accompanied by the emergence of contradictory information on smoking status. In 2015, 7 (2%) admissions had one location in the EMR (such as a documentation flow sheet) which indicated the patient used tobacco but another field in the same treatment episode (such as social history) indicated the patient was a nonsmoker. No admissions had contradictory information on smoking status in 2014.
Referral and Receipt of Counseling and Medications (TOB-2 and TOB-2a)
Compared to 2014, in 2015 there was a statistically significant increase in the number of patients referred for cessation counseling: 5 (4%) in 2014 and 110 (74%) in 2015; χ 2 = 127.44, df = 1, p < .001 (Table 2 ). The proportion of all identified tobacco users who actually received counseling was 9 (8%) tobacco users in 2014 and 100 (67%) tobacco users in 2015; χ 2 = 94.12, df = 1, p < .001. In 2015 there was also a statistically significant increase in the number of tobacco users referred for cessation medications. Over half (102; 68%) of tobacco users in 2015 were referred for cessation medications compared to 37 (32%) of tobacco users in 2014; χ 2 = 34.27, df = 1, p < .001 (Table 2) . However, while the proportion of tobacco users who actually received cessation medications increased from 28 (24%) in 2014 to 52 (35%) in 2015, this increase only approached statistical significance.
In both years, nicotine replacement therapy (NRT) was the only form of cessation medication prescribed for tobacco users while inpatients (not shown). There were several patients prescribed combination bupropion and NRT, but it was not possible to determine if bupropion was used in combination for cessation purposes, to treat primary psychiatric symptoms, or both.
Tobacco Use Characteristics and Counseling Details Among Treated Tobacco Users
Among tobacco users that completed cessation counseling, patients referred for counseling in 2014 tended to smoke more cigarettes per day, have a higher degree of nicotine dependence, and to have smoked for more years than patients referred in 2015 (Table 3) . In both years, patients were on average interested in quitting smoking, although patients in 2014 reported a higher interest in quitting, with a mean score of 8.1 on a scale of 0 (no interest) to 10 (highly interested). A higher proportion of patients in 2014 were interested in cessation medications at discharge, 5 (56%) versus 44 (44%) in 2015 (Table 3) . Patients in 2014 were also more interested in a referral to the state quitline, 4 (44%) versus 30 (31%), however few in either year accepted a referral to the text messaging service SmokeFreeTXT 22 ; 0 (0%) in 2014 versus 4 (4%) in 2015 (Table 3 ).
Screening and Treatment by Psychiatric Diagnosis
The Cochran-Mantel-Haenszel test was used to analyze pre-post CMS rule changes in our primary tobacco measures while simultaneously controlling for psychiatric diagnosis. In 2015, all admissions experienced increased odds of being screened for tobacco use OR = 5.19, p < .001. Similarly, in 2015, tobacco users experienced increased odds of being referred for counseling OR = 7.26, p < .001, receiving counseling OR = 22.99, p < .001, and being referred for medications OR = 6.29, p < .001. (Table 4 ). However, in 2015, tobacco users were as likely to receive medications as users in 2014. The Breslow-Day test which analyzes the odds ratio homogeneity between diagnostic groups, did not reach the level of significance for any outcome measures. Thus, there were no statistically significant differences in the odds ratios for the main outcome measures between diagnostic groups.
Discussion
Implementation of the CMS tobacco measures was associated with large and significant increases in screening for tobacco use, referrals for cessation counseling and medications, and receipt of cessation counseling. Increases in receipt of cessation medications were not statistically significant. Gains in screening and treatment did not differ across psychiatric diagnoses. It appears that, compared to patients receiving treatment in 2015, the nine psychiatric inpatients who received treatment in 2014 were more dependent smokers with a longer smoking history and greater motivation to quit. It is possible that patients who received cessation counseling in 2014 were referred because these patients experienced high levels of withdrawal symptoms.
It is important to note that tobacco treatment received from UKanQuit in 2015 appears less successful than treatment received in 2014, however, these percentages mask the overall impact. It appears paradoxical that, in 2014, 180% of patients who were referred for counseling via the EMR had documentation of counseling in the EMR. Prior to 2015-by invitation from a unit psychologistUKanQuit counselors occasionally attended group health education sessions in the psychiatric unit in order to provide patients with information on smoking cessation. Counselors followed up with individual counseling sessions for patients attending the groups who appeared interested in quitting. These individual counseling sessions-which UKanQuit staff did document in the EMR-occurred without a formal referral via the EMR, and were the reason that many more patients received counseling by UKanQuit than were referred by unit staff.
Conversely, in 2015, because the psychiatric unit adopted a population-based approach to tobacco treatment, the absolute number of patients receiving counseling was 10-times greater than in 2014. This translated to a much greater absolute number of patients receiving prescriptions for medications at discharge and referral to the state tobacco quitline. This illustrates the power of the proactive approach to tobacco treatment adopted in 2015, compared to the reactive approach used in 2014. Instead of addressing tobacco cessation only among highly dependent, motivated patients, engaging all tobacco users upon admission increased the number of patients who actually received cessation treatment.
The automatic referral process implemented in 2015-in which all identified tobacco users were by default referred to UKanQuit, was more effective in increasing cessation counseling than cessation medications. This may have been due to an existing policy of proactively providing NRT to all inpatients. This practice was instituted in 2006 when the hospital campus became tobacco free and psychiatric inpatients were no longer allowed to step outside for smoke breaks.
Our findings compare favorably to the impact of the Tobacco Tactics intervention. Duffy et al., 23 evaluated the effectiveness of an inpatient, nurse-administered tobacco control program for patients admitted for psychiatric conditions in two Veterans Affairs hospitals compared to a control hospital. Staff nurses in intervention sites received a 1-hour training in how to provide quit smoking brochures, assess interest in quitting, show interested patients a DVD on quitting smoking, provide additional counseling to quit, and work with physicians to initiate cessation medications. The percent of patients reporting receipt of several components increased significantly from the pre-to post-intervention time period for three components in the intervention sites, including group counseling (6.9% pre-intervention to 24.4% post-intervention, p = .05), nicotine patch (51.7% pre-intervention to 75.0% post-intervention, p = .04) and medications (3.5% pre-intervention to 24.4% post-intervention, p = .02). The 10-fold increase in counseling rates experienced by our hospital inpatients suggests that mandating treatment might result in even greater implementation-but perhaps only in the presence of a dedicated tobacco treatment service.
The increases in treatment delivery observed in our psychiatric unit may support the use of an automatic referral system to better engage patients in treatment. An automatic referral system results in the actual offer for cessation treatment taking place apart from the intake process which can be taxing to patients, especially to patients experiencing psychiatric symptoms, 2/3 of whom are admitted from the emergency department several hours after first coming in.
Similar to other studies, we found that psychiatric inpatients were interested in receiving treatment for tobacco dependence. 24, 25 After the CMS rule went into effect 44% expressed an interest in continuing cessation medications at discharge, and nearly one in three (31%) accepted a referral to the state tobacco quitline. This was similar to findings by Stocking et al., who observed a 27.9% quitline participation rate among psychiatric smokers offered services post discharge. 26 There were several limitations to our study. Because no control or comparison group was available, the changes in rates of services that we observed may have been due to an event other than the IPFQR program. We could not ascertain whether patients who were not referred for cessation medications had a medical contraindication or another reason for not being referred. Similarly, we could not determine why, in 2015, only 51% of patients referred for cessation medications actually received them. Anecdotally, unit staff reported that patients with lower levels of nicotine dependence often decline cessation medications at delivery, however, we could not verify such reports through documentation in the EMR.
Because we used only EMR fields and reports that were available across both years of the study, we also could not identify "when" screening actually occurred for patients. That is, we could not ascertain whether screening and treatment occurred within the 3-day window set by CMS or even within the present treatment encounter. In 2015, documentation of smoking status changed to include the use of a documentation flowsheet within the EMR, complete with date and time "stamps." Thus, for some patients in 2014, information regarding smoking history came solely from the social history section of the EMR which could have been entered at a previous treatment encounter. If we had been able to obtain the date that smoking history was entered into the social history, our screening rates for 2014 would have most likely been lower, while 2015 screening rates would have remained relatively unchanged. Furthermore, receipt of NRT and/or cessation counseling was used as a proxy for formal screening of tobacco use. Thus, it is possible that screening did not actually occur in some cases but was counted as having taken place if patients had independently requested NRT or cessation counseling during admission. Last, due to limited resources and time, we limited our analyses on screening and treatment to comparing differences across psychiatric diagnoses-future studies could examine differences in receipt of care based on patient demographics, inpatient medication record and smoking characteristics. The effects reported here cannot be attributed solely to the IPFQR program. Our findings may only be generalizable to other healthcare facilities with a dedicated tobacco treatment service in place similar to the UKanQuit program. Previous studies have demonstrated that hospitals participating in public reporting and pay for performance have been shown to achieve greater improvements in quality than hospitals participating in public reporting alone. 27 This study may also illustrate the potential effect that performance based penalties can have should facilities be required to do more than simply report on these tobacco measures.
This study exemplifies the impact these new reporting measures can have when psychiatric facilities move beyond letter of the policy, to continually assess organizational performance and implement changes to improve treatment delivery. With an estimated 1626 inpatient psychiatric facilities nationwide participating in the IPFQR program, 19 incentives for performance, in addition to reporting, could markedly increase tobacco treatment in the inpatient psychiatric population.
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